Mitinab is a prescription medication used to treat certain types of cancer, including:
- Chronic myeloid leukemia (CML)
- Acute lymphoblastic leukemia (ALL)
- Acute myeloid leukemia (AML)
- Myelodysplastic/myeloproliferative diseases (MDS/MPD)
Composition:
Each tablet of Mitinab contains 100mg of imatinib.
Mechanism of Action:
Imatinib works by:
- Inhibiting the activity of certain enzymes that are involved in the growth and survival of cancer cells
- Blocking the signaling pathways that are involved in the growth and survival of cancer cells
Uses:
Mitinab is used to treat:
- Chronic myeloid leukemia (CML) in chronic phase, accelerated phase, or blast crisis
- Acute lymphoblastic leukemia (ALL) in adults and children
- Acute myeloid leukemia (AML) in adults
- Myelodysplastic/myeloproliferative diseases (MDS/MPD)
Dosage:
The recommended dosage of Mitinab is:
- 100mg taken orally once daily, with food
Side Effects:
Common side effects of Mitinab include:
- Nausea and vomiting
- Diarrhea
- Fatigue
- Headache
- Abdominal pain
- Skin rash
- Increased risk of bleeding
- Increased risk of infections
Recommendation:
Mitinab is recommended for patients with chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), or myelodysplastic/myeloproliferative diseases (MDS/MPD) who have not responded to other treatments. Patients should also be advised to monitor their blood counts and liver function regularly during treatment.
Important Note:
Patients should not take Mitinab if they have a history of severe allergic reactions, kidney problems, or liver problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as heart problems or lung problems, before taking Mitinab.
Some common brands of imatinib include:
- Gleevec (Novartis)
- Glivec (Novartis)
Please note that Mitinab is not available in all markets and may be approved for different indications and dosages in different regions.
Reviews
There are no reviews yet.